Effects of dual antiplatelet therapy de-escalation on the prognosis of acute coronary syndrome patients at high risk of ischemia who underwent percutaneous coronary intervention

被引：0
|
作者：
Wang, Jingyao [1 ]
Li, Yachao [1 ]
Lei, Mengjie [1 ]
Yang, Yanli [1 ]
Gao, Haiyan [1 ]
Wang, Xiangjin [1 ]
An, Lei [1 ]
Zhou, Haili [1 ]
Sun, Xue [1 ]
Li, Cairong [1 ]
Zhao, Zhigang [1 ]
Xue, Zengming [1 ]
机构：
[1] Hebei Med Univ, Langfang Peoples Hosp, Dept Cardiol, Langfang Core Lab Precis Treatment Coronary Artery, 37 Xinhua Rd, Langfang 065000, Hebei, Peoples R China
来源：
CHINESE MEDICAL JOURNAL | 2024年 / 137卷 / 06期
关键词：
ACUTE MYOCARDIAL-INFARCTION; CLOPIDOGREL; TICAGRELOR;
D O I：
10.1097/CM9.0000000000003011
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：746 / 748
页数：3
相关论文
共 50 条
  • [21] Efficacy and Safety of De-escalation of Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome: A Meta-Analysis of Randomized Clinical Trials
    Bai, Nan
    Ma, Ying
    Niu, Ying
    Zhong, Peng-Yu
    Shang, Yao-Sheng
    Wang, Zhi-Lu
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2022, 80 (02) : 226 - 235
  • [22] Duration of Dual Antiplatelet Therapy in Patients with an Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
    Bavishi, Chirag
    Trivedi, Vrinda
    Singh, Mandeep
    Katz, Edward
    Messerli, Franz H.
    Bangalore, Sripal
    AMERICAN JOURNAL OF MEDICINE, 2017, 130 (11): : 1325.e1 - 1325.e12
  • [23] Dual antiplatelet therapy de-escalation in acute coronary syndrome: an individual patient meta-analysis
    Kang, Jeehoon
    Rizas, Konstantinos D.
    Park, Kyung Woo
    Chung, Jaewook
    van den Broek, Wout
    Claassens, Daniel M. F.
    Choo, Eun Ho
    Aradi, Daniel
    Massberg, Steffen
    Hwang, Doyeon
    Han, Jung-Kyu
    Yang, Han-Mo
    Kang, Hyun-Jae
    Chang, Kiyuk
    ten Berg, Jur M.
    Sibbing, Dirk
    Koo, Bon-Kwon
    Kim, Hyo-Soo
    EUROPEAN HEART JOURNAL, 2023, 44 (15) : 1360 - 1370
  • [24] De-Escalation of Dual Antiplatelet Regimens in East Asian Patients Undergoing Coronary Intervention
    Kim, Moo Hyun
    Choi, Sun Young
    Serebruany, Victor
    AMERICAN JOURNAL OF THERAPEUTICS, 2020, 27 (06) : E611 - E612
  • [25] De-Escalation of Dual Antiplatelet Therapy in Elderly Patients With Acute Coronary Syndrome: A Systematic Review and Meta-Analysis
    Fujisaki, Tomohiro
    Kuno, Toshiki
    Iwagami, Masao
    Miyamoto, Yoshihisa
    Takagi, Hisato
    Briasoulis, Alexandros
    Panaich, Sidakpal
    Latib, Azeem
    Kohsaka, Shun
    CIRCULATION, 2022, 146
  • [26] Antiplatelet Therapy and Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome and Thrombocytopenia
    Yusuf, Syed Wamique
    Iliescu, Cezar
    Bathina, Jaya D.
    Daher, Iyad N.
    Durand, Jean-Bernard
    TEXAS HEART INSTITUTE JOURNAL, 2010, 37 (03) : 336 - 340
  • [27] TRIPLE VERSUS DUAL ANTIPLATELET THERAPY IN PATIENTS WITH ACUTE CORONARY SYNDROME UNDERGOING PERCUTANEOUS CORONARY INTERVENTION
    Hu, Bin
    Zhou, Yujie
    Liu, Yuyang
    Shi, Dongmei
    Zhao, Yingxin
    Jia, Dean
    HEART, 2010, 96 : A107 - A107
  • [28] De-escalation of Dual Antiplatelet Therapy by Changing Ticagrelor to Clopidogrel Versus Ticagrelor Monotherapy in Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention
    Li, Yi-Heng
    Hsieh, I-Chang
    Lin, Hui-Wen
    Lin, Sheng-Hsiang
    CIRCULATION, 2024, 150
  • [29] De-escalation versus standard dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis
    Guo, Chen
    Li, Min
    Lv, Yong-Hui
    Zhang, Ming-Bo
    Wang, Zhi-Lu
    PLATELETS, 2020, 31 (01) : 15 - 25
  • [30] De-escalation of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome: An Updated Meta-analysis and Trial Sequential Analysis of 21 Studies and 38,741 Patients
    Hu, Meng-Jin
    Tan, Jiang-Shan
    Gao, Xiao-Jin
    Yang, Jin-Gang
    Yang, Yue-Jin
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2022, 79 (06) : 873 - 886
12345